Article List

WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2010> 21

Volume: 21

1. Combined open surgical and endovascular management of ruptured femoral artery from recurrent vulvar cancer.	Page:276—278
2. Sarcoma botryoides (embryonal rhabdomyosarcoma) of the uterine cervix in sisters.	Page:273—275
3. Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.	Page:269—272
4. The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.	Page:262—268
5. Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.	Page:255—261
6. Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer.	Page:248—254
7. Epidemiological characteristics of ovarian cancer in Korea.	Page:241—247
8. Outcomes of advanced and recurrent cervical cancer treated with cisplatin and generic topotecan: retrospective analysis in a tertiary care hospital in Thailand.	Page:237—240
9. The role of prophylactic cerclage in preventing preterm delivery after electrosurgical conization.	Page:230—236
10. Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage.	Page:225—229
11. In reply: A large-scale study on the role of ovarian symptom index is necessary.	Page:66—66
12. A hospital-based case-control study of identifying ovarian cancer using symptom index.	Page:65—65
13. Lipoleiomyoma of broad ligament mimicking ovarian cancer in a postmenopausal patient: case report and literature review.	Page:62—64
14. Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases.	Page:59—61
15. Cellular fibroma of the ovary containing Leydig cell hyperplasia: a case report.	Page:56—58
16. The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma.	Page:50—55
17. Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment.	Page:45—49
18. Proliferation of CD4(+)CD25(high+)Foxp3(+) regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.	Page:38—44
19. Global cooperation in gynecologic cancer.	Page:1—2
20. Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.	Page:3—11
21. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix.	Page:12—17
22. Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.	Page:18—23
23. Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers.	Page:24—28
24. Expression pattern of the class I homeobox genes in ovarian carcinoma.	Page:29—37
25. Prediction and prevention of preterm birth after cervical conization.	Page:207—208
26. Major clinical research advances in gynecologic cancer in 2010.	Page:209—218
27. The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective.	Page:219—224
28. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.	Page:97—101
29. The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.	Page:102—105
30. Wine drinking and epithelial ovarian cancer risk: a meta-analysis.	Page:112—118
31. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells.	Page:119—124
32. Growing teratoma syndrome in a post laparoscopic excision of ovarian immature teratoma.	Page:129—131
33. Proliferation of CD4(+)CD25(high+)Foxp3(+) regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.	Page:132—132
34. In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites.	Page:133—133
35. Co-occurrence of an adenoma malignum and an endocervical-type adenocarcinoma of the uterine cervix in a woman with Peutz-Jeghers syndrome.	Page:203—206
36. Primary amelanotic melanoma of the cervix: case report with review of literature.	Page:199—202
37. Skeletal muscle metastasis from carcinoma cervix: a case report.	Page:196—198
38. Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy.	Page:191—195
39. The type of metastasis is a prognostic factor in disseminated cervical cancer.	Page:186—190
40. High expression of mTOR is associated with radiation resistance in cervical cancer.	Page:181—185
41. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.	Page:174—180
42. GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer.	Page:169—173
43. Survival benefit of laparoscopic surgical staging-guided radiation therapy in locally advanced cervical cancer.	Page:163—168
44. Current status in the management of uterine corpus cancer in Korea.	Page:151—162
45. Asian society of gynecologic oncology workshop 2010.	Page:137—150
46. Overview on the 1st International Workshop on Gynecologic Oncology.	Page:135—136
47. Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer.	Page:106—111
48. Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature.	Page:125—128
49. Erratum: Global cooperation in gynecologic cancer.	Page:134—134
50. Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature.	Page:93—96
51. Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia.	Page:87—92
52. Identifying barriers to Papanicolaou smear screening in Korean women: Korean National Health and Nutrition Examination Survey 2005.	Page:81—86
53. Maximal cytoreductive effort in epithelial ovarian cancer surgery.	Page:75—80
54. Evolving strategies for ovarian cancer: gynecologic oncology in ASCO's 46th annual meeting.	Page:72—74
55. Towards eradication of cervical cancer: 4th biennial conference of the Asia Oceania research organization on Genital Infections & Neoplasia (AOGIN).	Page:70—71
56. Laparoscopic surgery is a current tide of widely accepted standard procedure for endometrial cancer.	Page:67—69